Top Markets
Coin of the day
Fusion Antibodies plc Fusion Antibodies plc

Fusion Antibodies plc

FAB
Peringkat dalam Saham #20442
Fusion Antibodies plc, a contract research organization, engages in the... Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally. It offers monoclonal antibody discovery and development, antibody sequencing, antibody engineering, antibody humanization and rational affinity maturation platform, recombinant protein expression, and stable cell line development and cGMP scale up services. The company serves pharmaceutical, biotech, and diagnostic companies. It has a collaboration partnership with Celonic AG. Fusion Antibodies plc was incorporated in 2000 and is headquartered in Belfast, the United Kingdom.
Harga Saham
$0.16328419
Kapitalisasi Pasar
$204.14K
Perubahan (1 hari)
4.35%
Perubahan (1 tahun)
102.45%
Negara
GB
Perdagangan Fusion Antibodies plc (FAB)

Kategori

EPS untuk Fusion Antibodies plc (FAB)
EPS per September 2025 TTM: $-0.02
Menurut laporan keuangan terbaru dan harga saham Fusion Antibodies plc, EPS perusahaan saat ini (TTM) adalah $-0.02. Pada akhir 2024, perusahaan memiliki EPS sebesar $-0.05 penurunan dibandingkan dengan EPS tahun 2023 sebesar $-0.12.
Riwayat EPS untuk Fusion Antibodies plc dari 2013 hingga 2026
EPS di akhir setiap tahun
Tahun EPS Mengubah
2026 (TTM) $-0.02 -3.00%
2025 $-0.02 -54.35%
2024 $-0.05 -58.93%
2023 $-0.12 102.30%
2022 $-0.06 -59.83%
2021 $-0.15 286.73%
2020 $-0.04 -47.38%
2019 $-0.07 22.53%
2018 $-0.06 -994.12%
2017 $0.01 -90.93%
2016 $0.08 -1,393.10%
2015 $-0.01 -31.76%
2014 $-0.01 -73.60%
2013 $-0.03 0.00%
EPS untuk perusahaan sejenis atau pesaing
Perusahaan EPS Perbedaan EPS Negara
$3.62 -18,771.65%
DK
$15.47 -79,842.27%
US
$43.12 -222,368.04%
US
$9.62 -49,691.75%
BE
$38.32 -197,625.77%
NL